固体器官移植受体体中的降脂剂
Agnieszka Mickiewicz1, Sławomir Żegleń2, Karolina Kędzierska-Kapuza3
1First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland.
概括
固体器官移植 (SOT) 接受者的脱脂症是常见的,治疗不足的心血管风险. 新型疗法和多学科护理对于管理脂质水平和改善患者的治疗结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植医学 移植医学
背景情况:
- 脱脂症是固体器官移植 (SOT) 接受者心血管事件的普遍,可修改的危险因素.
- 它经常被低估诊断和治疗,心血管事件,急性排斥和血管病变的相关风险被低估.
- 免疫抑制剂是SOT患者缺脂症的主要原因,需要谨慎管理.
研究的目的:
- 审查SOT接受者的脂质疾病的当前和未来的管理策略.
- 提出一种临床算法,用于脂质管理.
- 突出新型降脂疗法 (LLT) 的潜力,并鼓励进一步的研究.
主要方法:
- 对当前和新兴的降脂疗法进行文献综述.
- 讨论使用他类药物的挑战 (不坚持,药物相互作用).
- 强调综合护理的多学科团队方法.
主要成果:
- 新型LLT如PCSK9抑制剂和bempedoic酸,以及组合疗法 (ezetimibe/statin),显示出安全有效的LDL-C降低的希望.
- 随着这些不断变化的治疗选择,预计会改善坚持和结果.
- 需要根据器官类型和心血管风险量身定制的脂质治疗目标.
结论:
- 在复杂的SOT患者中,结构化,多学科的方法对于最佳的脂质管理至关重要.
- 新型LLT和组合疗法提供了更好的疗效和坚持.
- 需要进行进一步的试验和注册,以验证初始组合治疗策略,并评估新型LLTs的临床影响.
相关概念视频
01:28Kidney Transplant I: Introduction
65
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
65
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
884
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
884
01:26Kidney Transplant II: Surgical Procedure
78
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
78
01:16Kidney Transplant III: Nursing Management
85
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
85
01:24Tissue Transplantation
524
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
524